Retatrutide is a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these receptors, https://jimjtcp766118.csublogs.com/43502590/retatrutide-a-promising-new-treatment-for-obesity